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reg was originally identified a a gene expressed uring the regeneration of insulin-producing pancreatic /?-cells of the rat. We built an expression 
vector containing human reg cDNA to drive Saccharomyces cerevisiae to synthesize the reg protein, and purified it from the culture medium. The 
144-amino acid sequence of the recombinant protein was consistent with that deduced from the cDNA and genomic DNA sequence xcept that 
the signal sequence of 22 amino acids was eliminated, and the amino-terminal residue of the protein was pyroglutamic acid. The secondary structure 
of the reg protein was predicted by determination of the intramolecular cystine linkage and of a-helix and b-sheet contents. 
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1. INTRODUCTION 
In screening a cDNA library derived from rat 
regenerating islets [l-4], a novel gene, named reg 
(regenerating ene), was isolated [5-71; the gene was 
expressed in mouse hyperplastic islets as well as in rat 
regenerating islets, suggesting that its expression is 
associated with replication, growth or maturation of 
pancreatic endocrine cells [5-81. A human homologue 
to reg was also identified in a human pancreas-derived 
cDNA library; human and rat reg cDNAs encoded 166 
and 165 amino acid proteins containing signal se- 
quences [5-71. Recently, two proteins named pan- 
creatic stone protein (PSP) and pancreatic thread 
protein (PTP) were isolated from human pancreatic 
juice, and the amino acid sequences were determined 
[9, lo]. Since the amino acid sequence of human reg 
protein deduced from the reg cDNA sequence [5-71 
contains the sequences of PSP and of PTP and the 
human reg gene is a single copy gene [ 111, it is conclud- 
ed that the reg protein, PSP, and PTP are just different 
names for a single protein existing in several molecular 
forms but deriving from the reg gene [ll]. 
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In this study, we constructed an expression plasmid 
to direct the synthesis of human reg protein in S. 
cerevisiae and characterized the primary and secondary 
structures of the purified recombinant reg protein. 
2. EXPERIMENTAL 
2.1. Materials 
A yeast-Escherichia cob shuttle vector pAM82 carrying the PHOS 
promoter of the acid phosphatase gene [12] was a kind gift from Dr 
Kenichi Matsubara (Osaka University). Restriction endonucleases 
were purchased from Takara Shuzo Co. (Kyoto). S-Sepharose was 
from Pharmacia. Pyroglutamyl aminopeptidase from Boehringer 
Mannheim. Carboxypeptidases A and Y from Oriental Yeast Co. 
(Tokyo). Lysyl endopeptidase from Wako Pure Chemical Industries 
(Osaka). TPCK-treated trypsin from Sigma. Mouse anti-human reg 
protein monoclonal antibody was prepared in our laboratory using 
recombinant human reg protein [8,11]. Pancreas extract was 
prepared as described [ 1 I]. 
2.2. Construction of expression plasmid for human reg protein 
Human reg cDNA in hgtl0 [5] was digested with EcoRI and 
subcloned in PBS vector. The AflII/EcoRI fragment containing the 
5 ’ -terminal half of the human reg cDNA and the EcoRI/XbaI frag- 
ment containing the 3 ’ -terminal half were excised from the plasmids, 
and the Aj7II site (24 bp upstream of translational initiation codon) 
and the XbaI site (24 bp downstream of the stop codon) were con- 
verted into XhoI and NincII sites by utilizing XhoI and gafI linkers, 
respectively, thus forming a XhoI/HincII fragment, which was in- 
serted into pAM82 previously digested with XhoI and PvuII. The 
resultant recombinant plasmid (pAM82-human reg), shown in Fig. 1, 
thus provides all the appropriate transcriptional and translational 
signals for producing human reg protein in yeast. 
2.3. Production and purification of recombinant protein 
S. cerevisiae AH22 cells were transformed with the recombinant 
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Fig. 1. Schematic representation of the recombinant plasmid used for 
the expression of human reg protein. The hatched box in the plasmid 
represents the entire protein coding region in human reg cDNA. Open 
boxes represent 5’ and 3’ untranslated regions. The closed box 
represents the promoter region of PHOS in a shuttle vector (pAM82) 
with a replication origin (2/rori) and selection marker (leu2) that 
function in yeast. The direction of transcription of the human reg 
cDNA and the ampicillin resistant gene (GWI@‘) is shown by arrows, 
plasmid by the Iithium acetate method [13], and grown in Burkholder 
medium jl4] containing histidine (20 mg/l) at 30°C with aeration. 
Production of recombinant proteins was induced by ehminating Pi. 
S-Sepharose equilibrated with 0.05 M acetate buffer @H 3.4) was 
added to the culture medium that was adjusted to the same pH, 
followed by overnight agitation at 4”C, then packed into a column 
(4.4 x 50 cm), and washed, after which the proteins were eluted with 
0.5 M NaCl in the buffer. The eluates were dialyzed, reapplied to 
another S-Sepharose column (1.5 x 43 cm), and eluted with a linear 
gradient of 0.2 M to 0.5 M NaCl in the buffer. The fractions contain- 
ing proteins that displayed a single band at 16 kDa on SDS-PAGE 
were collected, concentrated and desalted by ultrafiltration with an 
Amicon YM-10 membrane. 
2.4. SDS-PAGE and Wesfern blot anaIysis 
Samples were subjected to SDS-PAGE [Is], transferred to a 
nitrocellulose filter 1161 and immunost~ned with an anti-human reg 
monoclonal antibody as described [I 11. 
2.5. Determination of amino acid composition and sequence 
The purified recombinant protein and peptide fragments were 
hydrolyzed in 4 M methanesulfonic acid containing 0.2% 
A 
3-(2-aminoethyl)indol at 110°C for 24 h, and analyzed by a Hitachi 
model 835 amino acid analyzer. Amino acid sequence was determined 
by automated Edman degradation using a protein sequencer 477A 
and a PTH analyzer 12OA (Applied Biosystems Inc.). 
3. RESULTS AND DISCUSSION 
Yeast cells carrying pAM82-human reg secreted 
predominantly a 16 kDa protein (Fig. 2A, lane 2, up- 
per arrow}, which reacted strongly with an antibody to 
human reg protein (Fig. 2B, lane 2). The 16 kDa pro- 
tein migrated on SDS-PAGE to almost the same posi- 
tion as the smaller molecular weight forms of 
pancreatic reg protein (Fig. 2B, lane 4). The 16 kDa 
recombinant protein purified by two cycles of S- 
Sepharose chromatography showed a single band on 
SDS-PAGE (Fig. 2A and B, lane 3). About 1 mg of the 
purified reg protein was obtained per liter of the culture 
medium. 
No PTH-amino acid was liberated at the first cycle 
of Edman degradation of the recombinant protein, but 
after the protein was digested with pyroglutamyl 
aminopeptidase the degradation reaction efficiently 
proceeded over 30 cycles, indicating that the amino- 
terminal residue is a pyroglutamic acid. As shown in 
Fig. 3, the amino terminal sequence was in agreement 
with positions l-30 of the sequence deduced from 
human reg cDNA and gene [5,11], indicating that the 
22-amino acid signal sequence had been eliminated in 
the 16 kDa protein. Carboxypeptidase A digestion of 
the S-carboxymethylated [ 171 protein released an 
asparagine residue, and subsequent carboxypeptidase Y 
digestion permitted confirmation of the 7 carboxyl- 
terminal residues, Phe( 138)-Vai-Cys-Lys-Fhe-Lys- 
Asn(144)COOH for the deduced human reg protein 
(Fig. 3). The amino acid composition of the 16 kDa 
protein was in good agreement with that deduced from 
the human reg cDNA and gene [S, 1 l] (data not shown). 
6 
Fig. 2. SDS-PAGE and immunoblotting analyses of recombinant and pancreatic reg proteins. Lane 1, condensed culture medium of 
untransformed AH22 cells; lane 2, condensed culture medium of pAM82-human reg-transformed AH22 cells; lane 3, purified recombinant human 
reg protein (1 fig); lane 4, human pancreas extract (3O/rg as protein); lane M, protein molecular mass markers (66, 45, 36, 29, 20.1, 14.2 kDa). 
Culture medium was condensed about lOO-fold, after which an aliquot (5 ~1) was loaded on each lane. Protein bands were visualized with 
Coomassie blue staining (A) or blotted onto nitrocellulose filters (B). Arrows indicate reg proteins. Molecutar sizes fin kDa) as estimated from 
marker proteins are shown on the left. 
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Fig. 3. Amino acid sequence of human reg protein. The sequence is 166 amino acids long [5] and numbered every 5 amino acids. The signal peptide 
is indicated by minus numbers. The vertical arrow shows the position at which the mature protein begins. The horizontal arrows indicate the 
residues determined by amino acid sequencing. The 6 cysteine residues involved in disulfide bond formation are boxed. 
To determine the disulfide linkage location between 
the 6 cysteine residues in the recombinant reg protein, 
the protein was digested with lysyl endopeptidase, and 
a part of the digest was S-carboxymethylated. As 
shown in Fig. 4A, when the HPLC elution profiles of 
non-S-carboxymethylated and S-carboxymethylated 
digests were compared, three peaks, 2, 4 and 5, in the 
non-4carboxymethylated sample were seen to have 
disappeared as a result of S-carboxymethylation. By 
amino acid composition and sequence analyses, peak 4 
was revealed to contain undigested reg protein: peak 2 
contained two peptides, Asp-129-Lys-135 and 
Ser-lOl-Lys-126, indicating the interconnection of 
Cys-115 and Cys-132 by a disulfide bond (see Fig. 3); 
peak 5 was composed of two peptides containing four 
half-cystine residues. The peak 5 peptides were then 
subjected to tryptic digestion, followed by separation 
on HPLC, which gave three peaks, 5TA, 5TB, and 5TC 
(Fig. 4B). 5TA consisted of the single polypeptide 
chain Glp-1-Arg-I 1 with no cysteine residue, 5TB con- 
sisted of two peptides, Ile-12-Arg-22 and 
Ser-23-Arg-32, and 5TC consisted of two peptides, 
Glu-33-Lys-67 and Phe-136-Lys-141, indicating that 
the position of disulfide bridges in the peak 5 peptides 
- 
32 40 50 60 
lb 20 30 40 50 
Time hn) 
Fig. 4. Separation of disulfide bond- or S-carboxymethylcysteine- 
containing peptides of the protease-digested recombinant human reg 
protein by reverse phase HPLC. The peptides were separated on a 
Vydac SC4 column (4.6 x 150 mm) with 50-min linear gradient from 
0% to 50% acetonitrile in 0.1% trifluoroacetic acid at a flow rate of 
1.0 ml/min. (A) Lysyl endopeptidase digested peptides: (A-l) non- 
carboxymethylated peptides; (A-2) carboxymethylated peptides. (B) 
Non-carboxymethylated tryptic peptides derived from the peptide in 
peak 5 (Fig. 4A). 
Fig. 5. Schematic representation of the secondary structure of 
recombinant human reg protein. The disulfide bonds are shown as 
the vertical or horizontal bars joining cysteine residues. The single- 
letter code for amino acids is used. 
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are Cys-14-Cys-25 and Cys-42-Cys-140. The a-helix 
and P-sheet contents of the recombinant human reg 
protein estimated by circular dichroism and by the 
Chou and Fasman algorithm 1181 were 12-17% and 
22-26%, respectively (data not shown). Thus, the 
secondary structure of the reg protein is predicted as 
shown in Fig. 5. 
The recombinant reg protein exhibited the following 
similarities to the naturally occurring human reg pro- 
tein (PSP/PTP). (i) The amino acid sequence of the 
recombinant protein was consistent with those of PSP 
[9,19] and PTP [lo]. (ii) The recombinant protein had 
the same cystine linkages (Fig. 5) as PSP [20]. (iii) The 
amino-terminal glutamine residue of the recombinant 
protein was converted to pyroglutamic acid residue as 
in the case of PSP [9]. (iv) The recombinant protein 
showed almost the same electrophoretic mobility as the 
smaller molecular weight form of the pancreatic pro- 
tein (Fig. 2). (v) The recombinant protein showed im- 
munoreactivity to an anti-reg protein antibody as did 
the pancreatic protein. 
PSP has been shown to have O-linked oligosac- 
charides [9] at Thr5, which accounts for the presence of 
larger molecular forms (Fig. 2B, lane 4). However, the 
recombinant human protein showed a single band at 
16 kDa on SDS-PAGE (Fig. 2B, lane 3), which cor- 
responded to the smaller molecular form of the pan- 
creatic protein. This suggests that the recombinant 
human reg protein synthesized in yeast is either not or 
only a little 0-glycosylated. In addition, minor 15 kDa 
proteins detected by SDS-PAGE (Fig. 2A, lane 2) and 
Western blotting (Fig. 2B, lane 2) began with Be12 
(Itoh, T., unpublished results), indicating that the 
15 kDa protein was generated by proteolytic cleavage 
between Arg-11 and Be-12 (see Fig. 3). The 15 kDa 
protein of 133 amino acids is thought to correspond to 
PSP Sl, which has been isolated from human pan- 
creatic juice [19]. We have also obtained recombinant 
rat reg protein in a similar way (unpublished results). 
These recombinant proteins should be useful for study- 
ing the biological functions of the reg protein or 
PSP/PTP both in vivo and in vitro. 
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